KR870007191A - 유기백금착물 및 이를 사용한 종양 치료방법 - Google Patents

유기백금착물 및 이를 사용한 종양 치료방법

Info

Publication number
KR870007191A
KR870007191A KR1019870000830A KR870000830A KR870007191A KR 870007191 A KR870007191 A KR 870007191A KR 1019870000830 A KR1019870000830 A KR 1019870000830A KR 870000830 A KR870000830 A KR 870000830A KR 870007191 A KR870007191 A KR 870007191A
Authority
KR
South Korea
Prior art keywords
same
treatment method
platinum complex
tumor treatment
organic platinum
Prior art date
Application number
KR1019870000830A
Other languages
English (en)
Other versions
KR900004404B1 (ko
Inventor
그래싱 차일드 랠프
비이타 파나요타
죤 래브카 조지프
양-이린
Original Assignee
아메리칸 사이아나밋드 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25241319&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR870007191(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 아메리칸 사이아나밋드 캄파니 filed Critical 아메리칸 사이아나밋드 캄파니
Publication of KR870007191A publication Critical patent/KR870007191A/ko
Application granted granted Critical
Publication of KR900004404B1 publication Critical patent/KR900004404B1/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F17/00Metallocenes
    • C07F17/02Metallocenes of metals of Groups 8, 9 or 10 of the Periodic Table
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086Platinum compounds
    • C07F15/0093Platinum compounds without a metal-carbon linkage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/02Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrane Compounds (AREA)
  • Furan Compounds (AREA)
  • Epoxy Compounds (AREA)
KR1019870000830A 1986-01-31 1987-01-31 유기백금착물 및 이를 사용한 종양 치료방법 KR900004404B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/824,404 US4880790A (en) 1986-01-31 1986-01-31 (Gem-heterocyclodimethanamine-N,N')platinum complexes
US824404 1986-01-31

Publications (2)

Publication Number Publication Date
KR870007191A true KR870007191A (ko) 1987-08-17
KR900004404B1 KR900004404B1 (ko) 1990-06-25

Family

ID=25241319

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019870000830A KR900004404B1 (ko) 1986-01-31 1987-01-31 유기백금착물 및 이를 사용한 종양 치료방법

Country Status (18)

Country Link
US (2) US4880790A (ko)
EP (1) EP0232784B1 (ko)
JP (1) JPS62246564A (ko)
KR (1) KR900004404B1 (ko)
AT (1) ATE82980T1 (ko)
AU (1) AU597932B2 (ko)
CA (1) CA1297113C (ko)
DE (1) DE3782831T2 (ko)
DK (1) DK50587A (ko)
ES (1) ES2052499T3 (ko)
FI (1) FI84271C (ko)
GR (1) GR3006594T3 (ko)
HU (1) HU204062B (ko)
IE (2) IE59743B1 (ko)
NO (1) NO870398L (ko)
NZ (1) NZ219093A (ko)
PH (1) PH24310A (ko)
ZA (1) ZA87713B (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870070A (en) * 1987-08-10 1989-09-26 American Cyanamid Company Water soluble platinum complexes of novel malonate derivatives
JP4899385B2 (ja) * 2005-09-06 2012-03-21 宇部興産株式会社 3−アミノメチルオキセタン化合物の製法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2195426B1 (ko) * 1972-08-09 1975-10-17 Lipha
NL7807334A (nl) * 1978-07-06 1980-01-08 Tno Platina-diaminecomplexen, werkwijze voor het bereiden daarvan, werkwijze voor het bereiden van een genees- middel met toepassing van een dergelijk platina-dia- minecomplex voor de behandeling van kanker, alsmede al- dus verkregen gevormd geneesmiddel.
NL8204067A (nl) * 1982-10-21 1984-05-16 Tno Platina-diaminecomplexen, werkwijze voor het bereiden daarvan, werkwijze voor het bereiden van een geneesmiddel met toepassing van een dergelijk platinadiaminecomplex voor de behandeling van kanker, alsmede aldus verkregen gevormd geneesmiddel.
US4500465A (en) * 1982-06-28 1985-02-19 Engelhard Corporation Solubilized platinum (II) complexes
DE3432320A1 (de) * 1984-09-03 1986-03-13 Behringwerke Ag, 3550 Marburg Cis-platin-komplexe mit einem pentaerythritderivat als liganden, verfahren zu ihrer herstellung und diese verbindungen enthaltendes pharmazeutisches mittel
JPS63112591A (ja) * 1986-10-29 1988-05-17 Nippon Kayaku Co Ltd 新規白金錯体
JPH112591A (ja) * 1997-06-11 1999-01-06 Taihei Kogyo Co Ltd サンプル片採取装置におけるサンプル切断位置の制御方法

Also Published As

Publication number Publication date
EP0232784A2 (en) 1987-08-19
DK50587A (da) 1987-08-01
AU597932B2 (en) 1990-06-14
FI870416A (fi) 1987-08-01
HUT44573A (en) 1988-03-28
DE3782831T2 (de) 1993-05-06
IE59743B1 (en) 1994-03-23
EP0232784A3 (en) 1989-05-31
GR3006594T3 (ko) 1993-06-30
PH24310A (en) 1990-05-29
CA1297113C (en) 1992-03-10
FI84271C (fi) 1991-11-11
EP0232784B1 (en) 1992-12-02
HU204062B (en) 1991-11-28
NZ219093A (en) 1990-03-27
US4880790A (en) 1989-11-14
AU6816787A (en) 1987-08-06
FI870416A0 (fi) 1987-01-30
IE870244L (en) 1987-07-31
ZA87713B (en) 1987-09-30
DK50587D0 (da) 1987-01-30
FI84271B (fi) 1991-07-31
NO870398D0 (no) 1987-01-30
ATE82980T1 (de) 1992-12-15
ES2052499T3 (es) 1994-07-16
KR900004404B1 (ko) 1990-06-25
NO870398L (no) 1987-08-03
IE870245L (en) 1987-07-31
JPS62246564A (ja) 1987-10-27
US6281365B1 (en) 2001-08-28
DE3782831D1 (de) 1993-01-14

Similar Documents

Publication Publication Date Title
BG45701A3 (en) Method for preparing of alpha- heterocyclic substituted tolunitriles
BG42837A3 (en) Method for preparing immunoglobulin derivatives of vinka alkaloides
FI932032A (fi) Kinazolinderivat foer oekande av antitumoeraktivitet
DE3850026D1 (de) Antigestagen- und antiöstrogenwirksame Verbindungen zur Behandlung hormonabhängiger Tumoren.
DE3667290D1 (de) Boronsaeureaddukte von technetium-99m-dioximkomplexen.
DE3777861D1 (de) Behandlung von gasen.
HUT44267A (en) Process for preparing new organic platinum complexes
ES8403157A1 (es) Un metodo de preparar sustancias biologicamente activas que tienen actividad anti-tumoral.
DE3888994D1 (de) Behandlung von androgener Alopecia mit 17-beta-n-mono-substituierten-carbamoyl-4-aza-5-alpha-androst-1-en-3-onen.
DE3684755D1 (de) Behandlung von tieren mit il-2, zubereitungen dafuer und ihre herstellung.
ES2058343T3 (es) Piridinas disubstituidas.
DE3687097D1 (de) Therapeutisches mittel zur behandlung haematopoietischer krankheiten.
DE3777656D1 (de) Mittel zur behandlung von alopezien.
KR870007191A (ko) 유기백금착물 및 이를 사용한 종양 치료방법
NL7811308A (nl) Werkwijze voor het bereiden vasn nieuwe derivaten van 2,6-difenyl-3,7-dioxabicyclo- 3,3,0-oc- taan-4,8-dion, deze nieuwe derivaten zelf en de toepas- sing ervan als actief bestanddeel in anti-tumormidde- len, catechol-o-methyltrans-ferase-vertragers en cyclische amp-fosfodieester-vertragers.
ATE87314T1 (de) Platin-arzneimittel.
SE456221B (sv) Liggunderlag for bestralningsanleggningar, fremst s k solarier
ATE269090T1 (de) Tiermodell zum testen von arzneistoffen zur behandlung von leukämie oder hiv
ES2004734A6 (es) Procedimiento de obtencion de conjugados biologicamente activos de metaloproteina-albumina o metaloproteina-albumina-anticuerpos
UA7415A1 (uk) Спосіб лікування ускладнених форм псоріазу
ATE73645T1 (de) Mittel zur behandlung von alopezien.
RU93034452A (ru) Производные хиназолинов для усиления противоопухолевой активности, способ их получения, способ лечения и фармацевтическая композиция
ATE74334T1 (de) Behandlung von gasen.
MY101025A (en) Anti-tumor method and compounds.
KR870011246A (ko) 인간 β-인터페론 유전자를 지닌 대장균 유전자 운반체의 제조방법

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19930421

Year of fee payment: 4

LAPS Lapse due to unpaid annual fee